To determine the number of MBC cases as well as the demographics, characteristics, and outcomes of MBC patients at Methodist Health System (MHS).
Male breast cancer (MBC) is a rare disease without sufficient clinical data supporting the management and treatment. The treatment of MBC arises from data extrapolated from female breast cancer (FBC). MBC has higher mortality than FBC. Previous studies have suggested differences between MBC and FBC; however, treatments remain the same for both. Larger studies in MBC are needed to provide more clinical data to help guide treatment.
Study Type
OBSERVATIONAL
Enrollment
8
To determine the number of MBC cases as well as the demographics, characteristics, and outcomes of MBC patients at Methodist Health System (MHS).
Clinical Research Institute at Methodist Health System
Dallas, Texas, United States
Diagnosis Rates of patients with MBC and FBC
complications of treatment
Time frame: 13 years
Recurrence rates of Patients with MBC and FBC
Recurrence rates of Patients with MBC and FBC
Time frame: 13 years
Duration of remission in Patients with MBC and FBC
Duration of remission in Patients with MBC and FBC
Time frame: 13 years
The Overall Survival of patients with MBC and FBC after receiving treatment
The Overall Survival of patients with MBC and FBC after receiving treatment
Time frame: 13 years
Determine the complications of Treatment in patients with MBC and FBC
Determine the complications of Treatment in patients with MBC and FBC
Time frame: 13 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.